About the 2nd Annual Biosimilars Forum (OCT, 2017)
The 2nd Annual Biosimilars Forum was hosted in Budapest, on October, 2017 by Accelsiors Ltd., clinicians, statisticians and regulatory representatives gathered together from around the world to share with each other their perspectives on this hot topic of research in lectures and informal discussions.
Please watch this short video with the key lecturers and the organizers of the forum summarizing their thoughts about the topic and sharing their experiences of this two days forum as an insight into the spirit of active brainstorming during the event.
Head of Clinical Development of Biologics, Gedeon Richter Plc.; Vice-Chair, Medicines for Europe, Biosimilar Medicines Group
Vice Chair, Department Clinical Pharmacology, Medical University of Vienna
Associate Professor, Medical Unversity of Vienna, Section for Medical Statistics
Statistician, Austrian Medicines and Medical Devices Agency; President, Viennese Section of IBS
Chief Scientific Officer, Accelsiors CRO Ltd.; President, Hungarian Society for Clinical Biostatistics
Consultant, Clinical Development and Pharmacovigilance
Planned topics for presentations and discussions:
EMA “Statistics for quality comparison” reflection paper is out for public consultation (problem statement, and feedback from industry received)
- Recent developments in assessing biosimilarity
- Clinical study designs
- Update on the last year review of the development program of registered Biosimilars in the EU (based on the EPARs)
SPEAKERS AND LECTURES
Places are limited in number. Please fill out and send us the Registration Form as soon as possible.
Registration deadline: 30th September, 2017
Two-day event: € 300
1st day course only: € 250
2nd day only: € 100
- WBS and ISCB members can attend the 2nd day symposium for free